Highlights

[PHARMA] QoQ Quarter Result on 2011-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 22-Feb-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 31-Dec-2011  [#4]
Profit Trend QoQ -     10.46%    YoY -     629.34%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 426,460 456,737 446,745 367,786 371,432 396,435 385,328 6.98%
  QoQ % -6.63% 2.24% 21.47% -0.98% -6.31% 2.88% -
  Horiz. % 110.67% 118.53% 115.94% 95.45% 96.39% 102.88% 100.00%
PBT 28,493 27,618 42,955 16,368 15,646 19,380 21,792 19.51%
  QoQ % 3.17% -35.70% 162.43% 4.61% -19.27% -11.07% -
  Horiz. % 130.75% 126.73% 197.11% 75.11% 71.80% 88.93% 100.00%
Tax -2,957 -11,541 -13,894 -4,186 -4,687 -5,335 -6,193 -38.83%
  QoQ % 74.38% 16.94% -231.92% 10.69% 12.15% 13.85% -
  Horiz. % 47.75% 186.36% 224.35% 67.59% 75.68% 86.15% 100.00%
NP 25,536 16,077 29,061 12,182 10,959 14,045 15,599 38.78%
  QoQ % 58.84% -44.68% 138.56% 11.16% -21.97% -9.96% -
  Horiz. % 163.70% 103.06% 186.30% 78.09% 70.25% 90.04% 100.00%
NP to SH 25,247 15,713 28,685 11,942 10,811 13,920 15,484 38.41%
  QoQ % 60.68% -45.22% 140.20% 10.46% -22.33% -10.10% -
  Horiz. % 163.05% 101.48% 185.26% 77.12% 69.82% 89.90% 100.00%
Tax Rate 10.38 % 41.79 % 32.35 % 25.57 % 29.96 % 27.53 % 28.42 % -48.81%
  QoQ % -75.16% 29.18% 26.52% -14.65% 8.83% -3.13% -
  Horiz. % 36.52% 147.04% 113.83% 89.97% 105.42% 96.87% 100.00%
Total Cost 400,924 440,660 417,684 355,604 360,473 382,390 369,729 5.53%
  QoQ % -9.02% 5.50% 17.46% -1.35% -5.73% 3.42% -
  Horiz. % 108.44% 119.18% 112.97% 96.18% 97.50% 103.42% 100.00%
Net Worth 496,469 481,394 474,161 514,153 464,092 451,517 437,661 8.74%
  QoQ % 3.13% 1.53% -7.78% 10.79% 2.79% 3.17% -
  Horiz. % 113.44% 109.99% 108.34% 117.48% 106.04% 103.17% 100.00%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 11,764 8,827 8,824 35,296 - - - -
  QoQ % 33.27% 0.04% -75.00% 0.00% 0.00% 0.00% -
  Horiz. % 33.33% 25.01% 25.00% 100.00% - - -
Div Payout % 46.60 % 56.18 % 30.76 % 295.57 % - % - % - % -
  QoQ % -17.05% 82.64% -89.59% 0.00% 0.00% 0.00% -
  Horiz. % 15.77% 19.01% 10.41% 100.00% - - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 496,469 481,394 474,161 514,153 464,092 451,517 437,661 8.74%
  QoQ % 3.13% 1.53% -7.78% 10.79% 2.79% 3.17% -
  Horiz. % 113.44% 109.99% 108.34% 117.48% 106.04% 103.17% 100.00%
NOSH 117,646 117,700 117,657 117,655 106,933 106,994 107,007 6.50%
  QoQ % -0.05% 0.04% 0.00% 10.03% -0.06% -0.01% -
  Horiz. % 109.94% 109.99% 109.95% 109.95% 99.93% 99.99% 100.00%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 5.99 % 3.52 % 6.51 % 3.31 % 2.95 % 3.54 % 4.05 % 29.72%
  QoQ % 70.17% -45.93% 96.68% 12.20% -16.67% -12.59% -
  Horiz. % 147.90% 86.91% 160.74% 81.73% 72.84% 87.41% 100.00%
ROE 5.09 % 3.26 % 6.05 % 2.32 % 2.33 % 3.08 % 3.54 % 27.31%
  QoQ % 56.13% -46.12% 160.78% -0.43% -24.35% -12.99% -
  Horiz. % 143.79% 92.09% 170.90% 65.54% 65.82% 87.01% 100.00%
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 362.49 388.05 379.70 312.60 347.35 370.52 360.09 0.44%
  QoQ % -6.59% 2.20% 21.47% -10.00% -6.25% 2.90% -
  Horiz. % 100.67% 107.76% 105.45% 86.81% 96.46% 102.90% 100.00%
EPS 21.46 13.35 24.38 10.15 10.11 13.01 14.47 29.96%
  QoQ % 60.75% -45.24% 140.20% 0.40% -22.29% -10.09% -
  Horiz. % 148.31% 92.26% 168.49% 70.15% 69.87% 89.91% 100.00%
DPS 10.00 7.50 7.50 30.00 0.00 0.00 0.00 -
  QoQ % 33.33% 0.00% -75.00% 0.00% 0.00% 0.00% -
  Horiz. % 33.33% 25.00% 25.00% 100.00% - - -
NAPS 4.2200 4.0900 4.0300 4.3700 4.3400 4.2200 4.0900 2.10%
  QoQ % 3.18% 1.49% -7.78% 0.69% 2.84% 3.18% -
  Horiz. % 103.18% 100.00% 98.53% 106.85% 106.11% 103.18% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 163.25 174.84 171.02 140.79 142.19 151.76 147.51 6.97%
  QoQ % -6.63% 2.23% 21.47% -0.98% -6.31% 2.88% -
  Horiz. % 110.67% 118.53% 115.94% 95.44% 96.39% 102.88% 100.00%
EPS 9.66 6.01 10.98 4.57 4.14 5.33 5.93 38.32%
  QoQ % 60.73% -45.26% 140.26% 10.39% -22.33% -10.12% -
  Horiz. % 162.90% 101.35% 185.16% 77.07% 69.81% 89.88% 100.00%
DPS 4.50 3.38 3.38 13.51 0.00 0.00 0.00 -
  QoQ % 33.14% 0.00% -74.98% 0.00% 0.00% 0.00% -
  Horiz. % 33.31% 25.02% 25.02% 100.00% - - -
NAPS 1.9005 1.8428 1.8151 1.9682 1.7766 1.7284 1.6754 8.74%
  QoQ % 3.13% 1.53% -7.78% 10.78% 2.79% 3.16% -
  Horiz. % 113.44% 109.99% 108.34% 117.48% 106.04% 103.16% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 7.5500 10.1800 5.9000 5.3600 5.9000 5.9000 5.7300 -
P/RPS 2.08 2.62 1.55 1.71 1.70 1.59 1.59 19.55%
  QoQ % -20.61% 69.03% -9.36% 0.59% 6.92% 0.00% -
  Horiz. % 130.82% 164.78% 97.48% 107.55% 106.92% 100.00% 100.00%
P/EPS 35.18 76.25 24.20 52.81 58.36 45.35 39.60 -7.57%
  QoQ % -53.86% 215.08% -54.18% -9.51% 28.69% 14.52% -
  Horiz. % 88.84% 192.55% 61.11% 133.36% 147.37% 114.52% 100.00%
EY 2.84 1.31 4.13 1.89 1.71 2.21 2.53 7.99%
  QoQ % 116.79% -68.28% 118.52% 10.53% -22.62% -12.65% -
  Horiz. % 112.25% 51.78% 163.24% 74.70% 67.59% 87.35% 100.00%
DY 1.32 0.74 1.27 5.60 0.00 0.00 0.00 -
  QoQ % 78.38% -41.73% -77.32% 0.00% 0.00% 0.00% -
  Horiz. % 23.57% 13.21% 22.68% 100.00% - - -
P/NAPS 1.79 2.49 1.46 1.23 1.36 1.40 1.40 17.75%
  QoQ % -28.11% 70.55% 18.70% -9.56% -2.86% 0.00% -
  Horiz. % 127.86% 177.86% 104.29% 87.86% 97.14% 100.00% 100.00%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 -
Price 8.2500 8.8300 5.9000 5.9000 5.9000 5.9000 5.0500 -
P/RPS 2.28 2.28 1.55 1.89 1.70 1.59 1.40 38.30%
  QoQ % 0.00% 47.10% -17.99% 11.18% 6.92% 13.57% -
  Horiz. % 162.86% 162.86% 110.71% 135.00% 121.43% 113.57% 100.00%
P/EPS 38.44 66.14 24.20 58.13 58.36 45.35 34.90 6.63%
  QoQ % -41.88% 173.31% -58.37% -0.39% 28.69% 29.94% -
  Horiz. % 110.14% 189.51% 69.34% 166.56% 167.22% 129.94% 100.00%
EY 2.60 1.51 4.13 1.72 1.71 2.21 2.87 -6.36%
  QoQ % 72.19% -63.44% 140.12% 0.58% -22.62% -23.00% -
  Horiz. % 90.59% 52.61% 143.90% 59.93% 59.58% 77.00% 100.00%
DY 1.21 0.85 1.27 5.08 0.00 0.00 0.00 -
  QoQ % 42.35% -33.07% -75.00% 0.00% 0.00% 0.00% -
  Horiz. % 23.82% 16.73% 25.00% 100.00% - - -
P/NAPS 1.95 2.16 1.46 1.35 1.36 1.40 1.23 35.85%
  QoQ % -9.72% 47.95% 8.15% -0.74% -2.86% 13.82% -
  Horiz. % 158.54% 175.61% 118.70% 109.76% 110.57% 113.82% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

243  655  547  1006 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.090.00 
 LCTITAN 2.15-0.25 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 DATAPRP 0.19-0.03 
 DGSB 0.225+0.01 
 HWGB 0.775+0.06 
 KSTAR 0.43+0.06 
 MTOUCHE 0.05-0.005 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS